AlphaYouLH
Schedule 13D filing
Lantheus Holdings, Inc. disclosed a 7.7% stake in Perspective Therapeutics, Inc. (CATX)
Lantheus Holdings, Inc. reported owning 7.7% of Perspective Therapeutics, Inc. (CATX) (8,739,011 shares) in a Schedule 13D filed Sep 23, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 23, 2026
- Source
- Schedule 13D
More CATX insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.